Upping the ante on antibodies.
The current generation of antibodies has done more than make a few companies rich. It has laid the groundwork for ambitious companies to move to maturity.
Baker
Monya
M
D000906:Antibodies / Q000737:chemistry*; D001665:Binding Sites; D001709:Biotechnology / Q000379:methods*; D002626:Chemistry, Pharmaceutical / Q000379:methods; D004345:Drug Industry / Q000379:methods / Q000639:trends; D005060:Europe; D005818:Genetic Engineering; D006801:Humans; D012109:Research Support as Topic; D014481:United States
D000906:Antibodies